185 related articles for article (PubMed ID: 36575626)
1. Sex-related differences and hormonal effects in the Dry Eye Assessment and Management (DREAM) study.
Zhao M; Yu Y; Roy NS; Ying GS; Asbell P; Bunya VY
Br J Ophthalmol; 2023 Dec; 108(1):23-29. PubMed ID: 36575626
[TBL] [Abstract][Full Text] [Related]
2. Age Associations with Dry Eye Clinical Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study.
Zhao M; Yu Y; Ying GS; Asbell PA; Bunya VY;
Ophthalmol Sci; 2023 Jun; 3(2):100270. PubMed ID: 36846104
[TBL] [Abstract][Full Text] [Related]
3. Association between systemic medication use and severity of dry eye signs and symptoms in the DRy eye assessment and management (DREAM) study.
Guo M; Diaz GM; Yu Y; Patel CA; Farrar JT; Asbell PA; Ying GS;
Ocul Surf; 2024 Apr; 32():112-119. PubMed ID: 38307463
[TBL] [Abstract][Full Text] [Related]
4. A latent profile analysis of tear cytokines and their association with severity of dry eye disease in the Dry Eye Assessment and Management (DREAM) study.
Chen Y; Mallem K; Asbell PA; Ying GS
Sci Rep; 2024 Jan; 14(1):526. PubMed ID: 38177232
[TBL] [Abstract][Full Text] [Related]
5. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study.
Yu K; Bunya V; Maguire M; Asbell P; Ying GS;
Ophthalmology; 2021 Oct; 128(10):1384-1392. PubMed ID: 33785415
[TBL] [Abstract][Full Text] [Related]
6. Dry Eye Subtypes in the Dry Eye Assessment and Management (DREAM) Study: A Latent Profile Analysis.
Yu K; Asbell PA; Shtein RM; Ying GS;
Transl Vis Sci Technol; 2022 Nov; 11(11):13. PubMed ID: 36383391
[TBL] [Abstract][Full Text] [Related]
7. Association Between Depression and Severity of Dry Eye Symptoms, Signs, and Inflammatory Markers in the DREAM Study.
Zhou Y; Murrough J; Yu Y; Roy N; Sayegh R; Asbell P; Maguire MG; Ying GS;
JAMA Ophthalmol; 2022 Apr; 140(4):392-399. PubMed ID: 35266971
[TBL] [Abstract][Full Text] [Related]
8. Association of Dry Eye Symptoms and Signs in Patients with Dry Eye Disease.
Tawfik A; Pistilli M; Maguire MG; Chen Y; Yu Y; Greiner JV; Asbell PA; Ying GS;
Ophthalmic Epidemiol; 2024 Jun; 31(3):274-282. PubMed ID: 37592829
[TBL] [Abstract][Full Text] [Related]
9. Association of Tear Cytokine Ratios with Symptoms and Signs of Dry Eye Disease: Biomarker Data from the Dry Eye Assessment and Management Study.
Zhao CS; Chen Y; Ying GS; Asbell PA;
Curr Eye Res; 2024 Jan; 49(1):16-24. PubMed ID: 37781912
[TBL] [Abstract][Full Text] [Related]
10. Climatic and Environmental Correlates of Dry Eye Disease Severity: A Report From the Dry Eye Assessment and Management (DREAM) Study.
Berg EJ; Ying GS; Maguire MG; Sheffield PE; Szczotka-Flynn LB; Asbell PA; Shen JF;
Transl Vis Sci Technol; 2020 Apr; 9(5):25. PubMed ID: 32821497
[TBL] [Abstract][Full Text] [Related]
11. Associations Between Systemic Omega-3 Fatty Acid Levels With Moderate-to-Severe Dry Eye Disease Signs and Symptoms at Baseline in the Dry Eye Assessment and Management Study.
Kuklinski EJ; Hom MM; Ying GS; Lin MC; Chapkin RS; Jones R; Moser A; Kim KY; Maguire MG; Asbell PA;
Eye Contact Lens; 2021 Jan; 47(1):2-7. PubMed ID: 32097181
[TBL] [Abstract][Full Text] [Related]
12. Dry Eye Disease in Patients with Functioning Filtering Blebs after Trabeculectomy.
Ji H; Zhu Y; Zhang Y; Li Z; Ge J; Zhuo Y
PLoS One; 2016; 11(3):e0152696. PubMed ID: 27032098
[TBL] [Abstract][Full Text] [Related]
13. Association of Tear Cytokine Concentrations with Symptoms and Signs of Dry Eye Disease: Baseline Data from the Dry Eye Assessment and Management (DREAM) Study.
Roy NS; Wei Y; Ying GS; Maguire MG; Asbell PA;
Curr Eye Res; 2023 Apr; 48(4):339-347. PubMed ID: 36632643
[TBL] [Abstract][Full Text] [Related]
14. Is there a relationship between the severity of disease in major depressive disorder patients and dry eye disease?
Gökçe GD; Metin M
Int Ophthalmol; 2024 Mar; 44(1):163. PubMed ID: 38551693
[TBL] [Abstract][Full Text] [Related]
15. Effects of Prolonged Reading on Dry Eye.
Karakus S; Agrawal D; Hindman HB; Henrich C; Ramulu PY; Akpek EK
Ophthalmology; 2018 Oct; 125(10):1500-1505. PubMed ID: 29705055
[TBL] [Abstract][Full Text] [Related]
16. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
Messmer EM; von Lindenfels V; Garbe A; Kampik A
Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated Tear Fluid Nociception-Associated Factors, Corneal Dendritic Cell Density, and Vitamin D Levels in Evaporative Dry Eye.
Khamar P; Nair AP; Shetty R; Vaidya T; Subramani M; Ponnalagu M; Dhamodaran K; D'souza S; Ghosh A; Pahuja N; Deshmukh R; Ahuja P; Sainani K; Nuijts RMMA; Das D; Ghosh A; Sethu S
Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2532-2542. PubMed ID: 31195410
[TBL] [Abstract][Full Text] [Related]
18. Association of Tear Osmolarity With Signs and Symptoms of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study.
Greiner JV; Ying GS; Pistilli M; Maguire MG; Asbell PA;
Invest Ophthalmol Vis Sci; 2023 Jan; 64(1):5. PubMed ID: 36626176
[TBL] [Abstract][Full Text] [Related]
19. Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome.
Ozek D; Kemer OE; Omma A
Arq Bras Oftalmol; 2019; 82(1):45-50. PubMed ID: 30403265
[TBL] [Abstract][Full Text] [Related]
20. Influence of video display terminal use and meibomian gland dysfunction on the ocular surface and tear neuromediators.
Bilgic AA; Kocabeyoglu S; Dikmetas O; Tan C; Karakaya J; Irkec M
Int Ophthalmol; 2023 May; 43(5):1537-1544. PubMed ID: 36239837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
